spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Insmed  

 HSMN NewsFeed - 23 May 2022
Insmed Names Drayton Wise Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 8 Jun 2020
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Apr 2020
Insmed Appoints Carol A. Schafer to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 30 Jan 2020
Insmed Appoints Sara Bonstein as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2020
Provention Bio Appoints Jason Hoitt as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2019
Patrick Coyle Appointed Vice President and Chief Financial Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Sep 2016
Insmed Appoints Roger Adsett as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2015
Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing
Devices Neurology Venture Capital Personnel
 HSMN NewsFeed - 7 Nov 2012
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 11 Sep 2012
Insmed Appoints Will Lewis as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 16 May 2012
Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2012
Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE(R) in Cystic Fibrosis Patients with Pseudomonas Lung Infections
Biopharmaceuticals
 HSMN NewsFeed - 23 Feb 2012
Satori Pharmaceuticals Raises $15M in New Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Jan 2012
Insmed Incorporated Provides Corporate Update
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2009
Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Feb 2009
Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Jul 2008
Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2008
Insmed Provides Update on IPLEX(TM) Programs
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2008
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Biopharmaceuticals Generics
 HSMN NewsFeed - 5 Feb 2008
Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Feb 2008
Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jun 2007
Experienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2007
Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 7 Mar 2007
Insmed Announces Restructure, Settlement Ending IPLEX(TM) Patent Dispute
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Mar 2007
Litigation Settlement Reached Between Tercica, Genentech and Insmed
Biopharmaceuticals Litigation
 HSMN NewsFeed - 10 Jan 2007
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
Biopharmaceuticals Neurology Licensing Distribution
 HSMN NewsFeed - 6 Dec 2006
Jury Finds Insmed Infringed Patents Owned By Genentech And Exclusively Licensed to Tercica
Biopharmaceuticals Litigation
 HSMN NewsFeed - 31 Oct 2006
Jody LoMenzo Named Director, Investor Relations and Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2006
ARCA Discovery, Inc. Names Thomas Keuer Executive Vice President of Pharmaceutical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2006
Former Amgen Manufacturing Executive Joins Insmed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2006
Insmed Sues Tercica for False Advertising
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Oct 2006
Insmed Provides Update Concerning Virginia Unfair Competition Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Jul 2006
Court Rules Insmed Infringes Tercica IGF-1 Process Patent
Biopharmaceuticals Litigation
Return to NewsFeed  

 Additional items found! 29

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 29 additional stories matching:
Insmed
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.